Groupama Asset Management’s Pfizer PFE Stock Holding History

Groupama Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Buy	63,984 +95	+0.1%	+$2.48K	0.02%	182
2026 Q1	$1.79M	Sell	63,889 -17,805	-22%	-$474K	0.03%	149
2025 Q4	$2.03M	Sell	81,694 -7,608	-9%	-$192K	0.03%	168
2025 Q3	$2.28M	Sell	89,302 -10,368	-10%	-$256K	0.03%	161
2025 Q2	$2.41M	Sell	99,670 -36,713	-27%	-$856K	0.04%	165
2025 Q1	$3.44M	Sell	136,383 -92,674	-40%	-$2.43M	0.07%	129
2024 Q4	$6.05M	Sell	229,057 -60,044	-21%	-$1.63M	0.12%	102
2024 Q3	$6.72M	Buy	289,101 +5,604	+2%	+$163K	0.17%	87
2024 Q2	$7.93M	Buy	283,497 +67,969	+32%	+$1.87M	0.11%	108
2024 Q1	$8.96M	Sell	215,528 -463,365	-68%	-$12.9M	0.16%	109
2023 Q4	$19.6M	Buy	+678,893	New	+$20.5M	0.51%	44

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Groupama Asset Management's PFE Position: Q2 2026 in Review

Groupama Asset Management increased its Pfizer (PFE) stake by 0.15% in Q2 2026, buying an estimated $2.48K and bringing the position to 63,984 shares worth $1.55M. The position accounts for 0.02% of the portfolio, ranked #182.

Groupama Asset Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.6M in Q4 2023. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Groupama Asset Management held 63,984 shares of Pfizer worth $1.55M as of Q2 2026.
Groupama Asset Management bought 95 Pfizer shares in Q2 2026, an estimated $2.48K.
Pfizer made up 0.02% of Groupama Asset Management's portfolio in Q2 2026, its #182 holding.
Groupama Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Groupama Asset Management's Pfizer position peaked at $19.6M in Q4 2023.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.